Variant report
Variant | esv33926 |
---|---|
Chromosome Location | chr20:30042485-30050786 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:30043021..30045109-chr20:30047141..30048737,2 | K562 | blood: | |
2 | chr20:30042574..30044997-chr20:30046543..30048384,2 | MCF-7 | breast: | |
3 | chr20:29900644..29901274-chr20:30041865..30042847,4 | MCF-7 | breast: | |
4 | chr20:30042574..30044997-chr20:30046543..30048384,2 | MCF-7 | breast: | |
5 | chr20:30048219..30048754-chr20:30090655..30091410,2 | MCF-7 | breast: | |
6 | chr20:30048029..30048980-chr20:30090666..30091556,3 | MCF-7 | breast: | |
7 | chr20:30043021..30045109-chr20:30047141..30048737,2 | K562 | blood: | |
8 | chr20:29900754..29901422-chr20:30042008..30042651,2 | MCF-7 | breast: | |
9 | chr20:30048218..30048964-chr20:30090625..30091177,2 | K562 | blood: | |
10 | chr20:30048067..30048963-chr20:30311751..30312260,2 | K562 | blood: | |
11 | chr20:30047555..30048272-chr4:189297803..189298552,2 | MCF-7 | breast: | |
12 | chr20:30050729..30053291-chr20:30054906..30056770,2 | K562 | blood: | |
13 | chr20:30045212..30046827-chr20:30114550..30117367,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000171552 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574367031 | chr20:30048046-30048047 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543369123 | chr20:30048075-30048076 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs560109581 | chr20:30048112-30048113 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs189506070 | chr20:30048113-30048114 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs371293984 | chr20:30048118-30048119 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs545626044 | chr20:30048147-30048148 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs374253105 | chr20:30048175-30048176 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs373509856 | chr20:30048201-30048202 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs368679089 | chr20:30048230-30048231 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs8119917 | chr20:30048318-30048319 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs528751371 | chr20:30048337-30048338 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs112623680 | chr20:30048351-30048352 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs377558666 | chr20:30048404-30048405 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs561161142 | chr20:30048407-30048408 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs568297397 | chr20:30048490-30048491 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs530084507 | chr20:30048496-30048497 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs371646915 | chr20:30048526-30048527 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs546561905 | chr20:30048564-30048565 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs566445594 | chr20:30048594-30048595 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs186633322 | chr20:30048618-30048619 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs551959586 | chr20:30048631-30048632 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs569031794 | chr20:30048656-30048657 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs79072922 | chr20:30048659-30048660 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs114440258 | chr20:30048698-30048699 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs56207446 | chr20:30048736-30048737 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs190677413 | chr20:30048737-30048738 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs553760298 | chr20:30048749-30048750 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs183181890 | chr20:30048753-30048754 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs145628437 | chr20:30048758-30048759 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs186429502 | chr20:30048761-30048762 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs191149331 | chr20:30048770-30048771 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs73232345 | chr20:30048773-30048774 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs182525056 | chr20:30048783-30048784 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs530100660 | chr20:30048837-30048838 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs187940831 | chr20:30048886-30048887 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs73116268 | chr20:30048906-30048907 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs538284673 | chr20:30048915-30048916 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs138191487 | chr20:30048918-30048919 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs552045572 | chr20:30048937-30048938 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs568993451 | chr20:30048961-30048962 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs150261121 | chr20:30049243-30049244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559182715 | chr20:30049282-30049283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575822127 | chr20:30049377-30049378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Autism | 22495311 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21806811 | CNVD |
Melanoma | 21693616 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:30048000-30048200 | Bivalent Enhancer | HepG2 | liver |
2 | chr20:30048000-30048400 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr20:30048000-30048400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
4 | chr20:30048000-30048400 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
5 | chr20:30048200-30048400 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |
6 | chr20:30048200-30048400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr20:30048200-30048400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr20:30048200-30048400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
9 | chr20:30049200-30049400 | Enhancers | Fetal Muscle Leg | muscle |